Calocurb’s active ingredient, Amarasate, a bitter extract derived from New Zealand-grown hops, has been validated through several clinical studies for its effectiveness in appetite control and weight management. In a 2019 randomized, placebo-controlled study published in Nutrients, Amarasate significantly reduced self-reported hunger by 30% in participants taking a high dose during a 24-hour intermittent fast. This effect was sustained for up to four hours, demonstrating its potential for enhancing satiety. A follow-up study further revealed that administering 500 mg of Amarasate to healthy men led to an 18% reduction in calorie intake during meals, accompanied by an increase in appetite-regulating hormones such as GLP-1, ghrelin, CCK, and PYY. Moreover, a study published in Obesity Pillars found that Amarasate significantly reduced appetite and cravings by approximately 40% in women during a 24-hour fast, with a more pronounced effect compared to men, highlighting a potential gender-specific sensitivity to GLP-1 stimulation. These findings are currently being expanded upon in a large-scale clinical trial involving 150 participants over six months, aimed at further exploring Amarasate’s impact on weight management and related biomarkers. Together, these studies underscore Amarasate’s promise as a natural, scientifically supported tool for managing appetite and supporting weight loss efforts.
CV Sciences Launches Cannabinoid-Free +PlusHlth Supplements
September 6, 2024
